Use of CD134 as a primary receptor by the feline immunodeficiency virus.
D000595:Amino Acid Sequence; D000818:Animals; D001596:Benzylamines; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism / Q000821:virology; D002415:Cats; D002460:Cell Line; D045744:Cell Line, Tumor; D000080027:Cyclams; D018076:DNA, Complementary; D015723:Gene Library; D006678:HIV / Q000378:metabolism; D006367:HeLa Cells; D006571:Heterocyclic Compounds / Q000494:pharmacology; D006801:Humans; D016089:Immunodeficiency Virus, Feline / Q000378:metabolism* / Q000472:pathogenicity; D051379:Mice; D008969:Molecular Sequence Data; D041681:NIH 3T3 Cells; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors / Q000378:metabolism; D053262:Receptors, OX40; D018124:Receptors, Tumor Necrosis Factor / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D011991:Receptors, Virus / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D013045:Species Specificity; D014161:Transduction, Genetic; D014162:Transfection
D001596:Benzylamines; D000080027:Cyclams; D018076:DNA, Complementary; D006571:Heterocyclic Compounds; D019718:Receptors, CXCR4; D053262:Receptors, OX40; D018124:Receptors, Tumor Necrosis Factor; D011991:Receptors, Virus; C505716:TNFRSF4 protein, human; C505717:Tnfrsf4 protein, mouse; C088327:plerixafor